Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors

Fig. 2

Differential expression of m6A related players among NCCIT parental and resistant cell line clones. A: Relative mRNA expression levels of METTL3, WTAP, VIRMA, METTL14, METTL4, YTHDF3, ALKBH5 and FTO. Results are normalized to GUSB/18S rRNA, computed in 2^-ΔΔCt format and expressed as fold-change compared to NCCIT-P levels; B: Relative protein expression levels of METTL3, VIRMA, WTAP and METTL14. Results are normalized to ß-actin and expressed as fold-change compared to NCCIT-P levels. * p < 0.05

Back to article page